Dechra Pharmaceuticals competitors

Dechra Pharmaceuticals Competitors include Biogen, Otonomy, Pfizer and PetLife Pharmaceuticals.
Add company...
Dechra Pharmaceuticals
Dechra Pharmaceuticals
A growing global veterinary brand, providing the most appropriate therapeutic solutions and the best support to help you care for companion animals.
Biogen
Biogen
Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Pfizer
Pfizer
Pfizer is a biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
PetLife Pharmaceuticals
PetLife Pharmaceuticals
PetLife Pharmaceuticals is a registered U.S. Veterinary Pharmaceutical company whose mission is to bring its scientifically proven, bioactive medication and nutraceuticals to the world of veterinary oncology.
Founding Date
Founding Date
1997
Founding Date
1978
Founding Date
2008
Founding Date
1849
Founding Date
2016
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Lostock Gralam, GB HQ
Dornbirn, AT
Pointe Claire, CA
Uldum, DK
Montigny Le Bretonneux, FR
Aulendorf, DE
Torino, IT
see more
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Locations
New York, US HQ
Buenos Aires, AR
Melrose Park, AU
Wien, AT
Minsk, BY
Ixelles, BE
Sofia, BG
see more
Locations
Hancock, US HQ
Employees
Employees
1,3382% increase
Employees
7,300
Employees
139
Employees
90,2007% decrease
Employees
5
Valuation ($)
Valuation ($)
2.5 b
Valuation ($)
68.2 b
Valuation ($)
61.3 m
Valuation ($)
245.5 b
Valuation ($)
6.3 m
Twitter followers
Twitter followers
2.2 k
Twitter followers
19.4 k
Twitter followers
267
Twitter followers
13.3 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
£407.1m (FY, 2018)
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
$1.2m (FY, 2017)
Revenue (est.)
$52.5b (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
£184.7m (FY, 2018)
Cost of goods
N/A
Cost of goods
$3.1m (FY, 2017)
Cost of goods
$11.2b (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
£222.4m (FY, 2018)
Gross profit
N/A
Gross profit
($1.9m) (FY, 2017)
Gross profit
$41.3b (FY, 2017)
Gross profit
N/A
Net income
Net income
£36.1m (FY, 2018)
Net income
$3.7b (FY, 2016)
Net income
($90.1m) (FY, 2017)
Net income
$21.3b (FY, 2017)
Net income
N/A

Operating

Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
29 (FY, 2017)
Phase III Trials Products
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,300

Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.

View company
Otonomy
HQ
San Diego, US
Employees
139

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company
Pfizer
HQ
New York, US
Employees
90,200↓ 7% decrease

Pfizer is a biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.

View company
PetLife Pharmaceuticals
HQ
Hancock, US
Employees
5

PetLife Pharmaceuticals is a registered U.S. Veterinary Pharmaceutical company whose mission is to bring its scientifically proven, bioactive medication and nutraceuticals to the world of veterinary oncology.

View company